Maryland Oncology Hematology, P.A.

Clinical research site in Rockville, Maryland · 9905 MEDICAL CENTER DR STE 300, ROCKVILLE, MD 20850-6535 · (240) 238-3566 · Website

Part of Maryland Oncology Hematology

As of July 2026, 6 paid clinical trials are recruiting at Maryland Oncology Hematology, P.A. in Rockville, Maryland. Active studies at this site cover conditions such as Carcinoma, Non-Small Cell Lung and Metastatic Castration-resistant Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Maryland Oncology Hematology, P.A. (6)

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma

61 locations incl. Los Angeles

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07392892·Phase 2, Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Advanced Non-Small Cell Lung Cancer

186 locations incl. Bullhead City

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for Non-small Cell Carcinoma

133 locations incl. Alabaster

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for Breast Cancer

102 locations incl. Chandler

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

for Carcinoma, Non-Small Cell Lung

9 locations incl. Los Angeles

Sponsor: Genprex, Inc.

Sex: All·Age: 18+

Code: NCT04486833·Phase 1, Phase 2·Recruiting·Listed Jul 2020

Apply to this trial

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

9 locations incl. Aurora

Sponsor: BioNTech SE

Sex: Male·Age: 18+

Code: NCT07365995·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

More research sites in Rockville

Sunstone Medical, PC (5 trials)
Shady Grove Fertility (4 trials)
Maryland Treatment Centers - Avery Road Treatment Center (3 trials)
National Cancer Institute - Shady Grove (3 trials)
Sunstone Therapies (3 trials)
Velocity Clinical Research, Rockville (3 trials)
Adventist HealthCare Shady Grove Medical Center (2 trials)
Dermatology and Skin Cancer Specialists, LLC (2 trials)
Endo And Metab Cons (2 trials)
GSK Investigational Site (2 trials)

Explore more

Paid clinical trials in Rockville, MD · Maryland clinical trials